A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients

INTRODUCTION: Alzheimer’s disease (AD) is the most common neurodegenerative form of dementia. Pharmacological therapies for symptomatic treatment, such as acetylcholinesterase inhibitors (AChEIs) and memantine, have been available in the USA since 2000. Over the past decade, few studies have analyze...

Descripción completa

Detalles Bibliográficos
Autores principales: Bent-Ennakhil, Nawal, Coste, Florence, Xie, Lin, Aigbogun, Myrlene Sanon, Wang, Yuexi, Kariburyo, Furaha, Hartry, Ann, Baser, Onur, Neumann, Peter, Fillit, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447560/
https://www.ncbi.nlm.nih.gov/pubmed/28508250
http://dx.doi.org/10.1007/s40120-017-0067-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447560/
https://www.ncbi.nlm.nih.gov/pubmed/28508250
http://dx.doi.org/10.1007/s40120-017-0067-7

Ejemplares similares